Cosciens Biopharma Inc (CSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 11-1996 | 08-1996 | 05-1996 | 02-1996 | 11-1995 | |
| Gross Profit | 1,314 | 1,349 | 1,854 | 1,790 | 1,368 |
| Operating Expenses | 202 | 84 | 277 | 229 | 202 |
| Operating Income | -202 | -84 | -277 | -229 | -202 |
| Pre-tax Income | -202 | -84 | -277 | -229 | -202 |
| Net Income Continuous | -202 | -84 | -277 | -229 | -202 |
| Net Income | $-202 | $-84 | $-277 | $-229 | $-202 |
| EBITDA(a) | $107 | $1,209 | $-277 | $-229 | $-202 |